Annual Shareholders Equity
$649.30 M
-$738.40 M-53.21%
31 December 2023
Summary:
Emergent BioSolutions annual stockholders equity is currently $649.30 million, with the most recent change of -$738.40 million (-53.21%) on 31 December 2023. During the last 3 years, it has fallen by -$797.70 million (-55.13%). EBS annual shareholders equity is now -59.71% below its all-time high of $1.61 billion, reached on 31 December 2021.EBS Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Shareholders Equity
$508.40 M
+$122.10 M+31.61%
30 September 2024
Summary:
Emergent BioSolutions quarterly stockholders equity is currently $508.40 million, with the most recent change of +$122.10 million (+31.61%) on 30 September 2024. Over the past year, it has dropped by -$188.80 million (-27.08%). EBS quarterly shareholders equity is now -68.45% below its all-time high of $1.61 billion, reached on 31 December 2021.EBS Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
EBS Shareholders Equity Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -53.2% | -27.1% |
| 3 y3 years | -55.1% | -66.6% |
| 5 y5 years | -35.8% | -50.9% |
EBS Shareholders Equity High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -59.7% | at low | -68.5% | +31.6% |
| 5 y | 5 years | -59.7% | at low | -68.5% | +31.6% |
| alltime | all time | -59.7% | +2110.5% | -68.5% | +2115.3% |
Emergent BioSolutions Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $508.40 M(+31.6%) |
| June 2024 | - | $386.30 M(-41.8%) |
| Mar 2024 | - | $663.90 M(+2.2%) |
| Dec 2023 | $649.30 M(-53.2%) | $649.30 M(-6.9%) |
| Sept 2023 | - | $697.20 M(-27.1%) |
| June 2023 | - | $956.30 M(-20.5%) |
| Mar 2023 | - | $1.20 B(-13.3%) |
| Dec 2022 | $1.39 B(-13.9%) | $1.39 B(-4.3%) |
| Sept 2022 | - | $1.45 B(-4.2%) |
| June 2022 | - | $1.51 B(-3.9%) |
| Mar 2022 | - | $1.58 B(-2.2%) |
| Dec 2021 | $1.61 B(+11.4%) | $1.61 B(+5.8%) |
| Sept 2021 | - | $1.52 B(-1.4%) |
| June 2021 | - | $1.54 B(+1.4%) |
| Mar 2021 | - | $1.52 B(+5.2%) |
| Dec 2020 | $1.45 B(+32.9%) | $1.45 B(+15.6%) |
| Sept 2020 | - | $1.25 B(+4.4%) |
| June 2020 | - | $1.20 B(+11.5%) |
| Mar 2020 | - | $1.07 B(-1.3%) |
| Dec 2019 | $1.09 B(+7.7%) | $1.09 B(+5.2%) |
| Sept 2019 | - | $1.03 B(+4.7%) |
| June 2019 | - | $988.90 M(+0.1%) |
| Mar 2019 | - | $987.50 M(-2.3%) |
| Dec 2018 | $1.01 B(+10.8%) | $1.01 B(+4.6%) |
| Sept 2018 | - | $966.65 M(+3.0%) |
| June 2018 | - | $938.35 M(+6.5%) |
| Mar 2018 | - | $881.28 M(-3.4%) |
| Dec 2017 | $912.30 M(+53.0%) | $912.30 M(+37.5%) |
| Sept 2017 | - | $663.71 M(+6.9%) |
| June 2017 | - | $620.60 M(+1.7%) |
| Mar 2017 | - | $610.42 M(+2.4%) |
| Dec 2016 | $596.21 M(-9.7%) | $596.21 M(+8.9%) |
| Sept 2016 | - | $547.62 M(-18.6%) |
| June 2016 | - | $672.67 M(+0.9%) |
| Mar 2016 | - | $666.98 M(+1.1%) |
| Dec 2015 | $660.02 M | $660.02 M(+9.0%) |
| Sept 2015 | - | $605.31 M(+7.7%) |
| June 2015 | - | $562.25 M(+4.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2015 | - | $537.88 M(-2.8%) |
| Dec 2014 | $553.20 M(+13.0%) | $553.20 M(+7.8%) |
| Sept 2014 | - | $513.14 M(+5.2%) |
| June 2014 | - | $487.77 M(+2.2%) |
| Mar 2014 | - | $477.50 M(-2.5%) |
| Dec 2013 | $489.62 M(+10.9%) | $489.62 M(+4.8%) |
| Sept 2013 | - | $467.31 M(+4.0%) |
| June 2013 | - | $449.53 M(+3.2%) |
| Mar 2013 | - | $435.59 M(-1.3%) |
| Dec 2012 | $441.36 M(+6.5%) | $441.36 M(+3.4%) |
| Sept 2012 | - | $427.04 M(+1.8%) |
| June 2012 | - | $419.69 M(+2.5%) |
| Mar 2012 | - | $409.59 M(-1.1%) |
| Dec 2011 | $414.25 M(+12.1%) | $414.25 M(+8.6%) |
| Sept 2011 | - | $381.29 M(+1.1%) |
| June 2011 | - | $377.25 M(+6.6%) |
| Mar 2011 | - | $354.05 M(-4.2%) |
| Dec 2010 | $369.46 M(+53.2%) | $369.46 M(+33.7%) |
| Sept 2010 | - | $276.29 M(+6.2%) |
| June 2010 | - | $260.22 M(+5.3%) |
| Mar 2010 | - | $247.09 M(+2.4%) |
| Dec 2009 | $241.20 M(+21.0%) | $241.20 M(+2.5%) |
| Sept 2009 | - | $235.38 M(+2.9%) |
| June 2009 | - | $228.85 M(+7.9%) |
| Mar 2009 | - | $212.09 M(+6.4%) |
| Dec 2008 | $199.35 M(+16.5%) | $199.35 M(+3.4%) |
| Sept 2008 | - | $192.83 M(+6.5%) |
| June 2008 | - | $181.12 M(+1.4%) |
| Mar 2008 | - | $178.60 M(+4.3%) |
| Dec 2007 | $171.16 M(+23.6%) | $171.16 M(+19.3%) |
| Sept 2007 | - | $143.49 M(+2.5%) |
| June 2007 | - | $140.02 M(+1.4%) |
| Mar 2007 | - | $138.02 M(-0.3%) |
| Dec 2006 | $138.47 M(+131.8%) | $138.47 M(+144.0%) |
| Sept 2006 | - | $56.76 M(-5.0%) |
| Dec 2005 | $59.74 M(+160.3%) | $59.74 M(+160.3%) |
| Dec 2004 | $22.95 M(+452.3%) | $22.95 M |
| Dec 2002 | $4.16 M(-112.9%) | - |
| Dec 2001 | -$32.30 M | - |
FAQ
- What is Emergent BioSolutions annual stockholders equity?
- What is the all time high annual shareholders equity for Emergent BioSolutions?
- What is Emergent BioSolutions annual shareholders equity year-on-year change?
- What is Emergent BioSolutions quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for Emergent BioSolutions?
- What is Emergent BioSolutions quarterly shareholders equity year-on-year change?
What is Emergent BioSolutions annual stockholders equity?
The current annual shareholders equity of EBS is $649.30 M
What is the all time high annual shareholders equity for Emergent BioSolutions?
Emergent BioSolutions all-time high annual stockholders equity is $1.61 B
What is Emergent BioSolutions annual shareholders equity year-on-year change?
Over the past year, EBS annual stockholders equity has changed by -$738.40 M (-53.21%)
What is Emergent BioSolutions quarterly stockholders equity?
The current quarterly shareholders equity of EBS is $508.40 M
What is the all time high quarterly shareholders equity for Emergent BioSolutions?
Emergent BioSolutions all-time high quarterly stockholders equity is $1.61 B
What is Emergent BioSolutions quarterly shareholders equity year-on-year change?
Over the past year, EBS quarterly stockholders equity has changed by -$188.80 M (-27.08%)